{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:19:36Z","timestamp":1770495576413,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s13304-022-01340-3","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T12:06:35Z","timestamp":1659787595000},"page":"1715-1723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5764-5606","authenticated-orcid":false,"given":"Antonio","family":"Sommariva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pizzolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Cenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marica","family":"Mirabella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Pilati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"1340_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ctrv.2011.07.001","volume":"38","author":"A Sommariva","year":"2012","unstructured":"Sommariva A, Pilati P, Rossi CR (2012) Cyto-reductive surgery combined with hyperthermic intra-peritoneal chemotherapy for peritoneal surface malignancies: current treatment and results. Cancer Treat Rev 38:258\u2013268. https:\/\/doi.org\/10.1016\/j.ctrv.2011.07.001","journal-title":"Cancer Treat Rev"},{"key":"1340_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.6363","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA et al (2021) The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surg. https:\/\/doi.org\/10.1001\/jamasurg.2020.6363","journal-title":"JAMA Surg"},{"key":"1340_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1245\/s10434-017-6293-5","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, Sugarbaker P, Deraco M, Morris D, Glehen O, Elias D et al (2018) Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the peritoneal surface oncology group international registry. Ann Surg Oncol 25:667\u2013673. https:\/\/doi.org\/10.1245\/s10434-017-6293-5","journal-title":"Ann Surg Oncol"},{"key":"1340_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/nejmoa1708618","volume":"378","author":"WJ van Driel","year":"2018","unstructured":"van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM et al (2018) Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med 378:230\u2013240. https:\/\/doi.org\/10.1056\/nejmoa1708618","journal-title":"N Engl J Med"},{"key":"1340_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M et al (2021) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22:256\u2013266. https:\/\/doi.org\/10.1016\/S1470-2045(20)30599-4","journal-title":"Lancet Oncol"},{"key":"1340_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejso.2020.10.006","volume":"47","author":"A Brandl","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B (2021) Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI. Eur J Surg Oncol 47:172\u2013180. https:\/\/doi.org\/10.1016\/j.ejso.2020.10.006","journal-title":"Eur J Surg Oncol"},{"key":"1340_CR7","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality. Ann Surg 249:900\u2013907. https:\/\/doi.org\/10.1097\/SLA.0b013e3181a45d86","journal-title":"Ann Surg"},{"key":"1340_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6847","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6847","journal-title":"JAMA Netw Open"},{"key":"1340_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jso.20013","volume":"85","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Van Tinteren H, Ruth SV, Zoetmulder FAN (2004) Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 85:61\u201367. https:\/\/doi.org\/10.1002\/jso.20013","journal-title":"J Surg Oncol"},{"key":"1340_CR10","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1245\/s10434-019-07414-8","volume":"26","author":"S Khan","year":"2019","unstructured":"Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM (2019) Incidence, risk factors, and prevention strategies for venous thromboembolism after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 26:2276\u20132284. https:\/\/doi.org\/10.1245\/s10434-019-07414-8","journal-title":"Ann Surg Oncol"},{"key":"1340_CR11","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1245\/s10434-016-5143-1","volume":"23","author":"T Charrier","year":"2016","unstructured":"Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Qu\u00e9net F et al (2016) Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy with oxaliplatin increases the risk of postoperative hemorrhagic complications: analysis of predictive factors. Ann Surg Oncol 23:2315\u20132322. https:\/\/doi.org\/10.1245\/s10434-016-5143-1","journal-title":"Ann Surg Oncol"},{"key":"1340_CR12","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","volume":"46","author":"M H\u00fcbner","year":"2020","unstructured":"H\u00fcbner M, Kusamura S, Villeneuve L, Al-Niaimi A, Alyami M, Balonov K et al (2020) Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u2014part I: preoperative and intraoperative management. Eur J Surg Oncol 46:2292\u20132310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041","journal-title":"Eur J Surg Oncol"},{"key":"1340_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s12630-017-0952-7","volume":"64","author":"H Hurdle","year":"2017","unstructured":"Hurdle H, Bishop G, Walker A, Moazeni A, Paloucci EO, Temple W et al (2017) Coagulation after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a retrospective cohort analysis. Can J Anesth 64:1144\u20131152. https:\/\/doi.org\/10.1007\/s12630-017-0952-7","journal-title":"Can J Anesth"},{"key":"1340_CR14","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejso.2016.09.008","volume":"43","author":"C Rasp\u00e9","year":"2017","unstructured":"Rasp\u00e9 C, Fl\u00f6ther L, Schneider R, Bucher M, Piso P (2017) Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 43:1013\u20131027. https:\/\/doi.org\/10.1016\/j.ejso.2016.09.008","journal-title":"Eur J Surg Oncol"},{"key":"1340_CR15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.amjsurg.2019.01.034","volume":"217","author":"DA Teoh","year":"2019","unstructured":"Teoh DA, Hutton MJH, Else S, Walker A, Lee A, Mack LA (2019) Epidural analgesia? A prospective analysis of perioperative coagulation in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Am J Surg 217:887\u2013892. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.01.034","journal-title":"Am J Surg"},{"key":"1340_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","journal-title":"Ann Surg"},{"key":"1340_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jso.21068","volume":"98","author":"AG Portilla","year":"2008","unstructured":"Portilla AG, Shigeki K, Dario B, Marcello D (2008) The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 98:228\u2013231. https:\/\/doi.org\/10.1002\/jso.21068","journal-title":"J Surg Oncol"},{"key":"1340_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jso.21072","volume":"98","author":"S Gonz\u00e1lez-Moreno","year":"2008","unstructured":"Gonz\u00e1lez-Moreno S, Kusamura S, Baratti D, Deraco M (2008) Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 98:237\u2013241. https:\/\/doi.org\/10.1002\/jso.21072","journal-title":"J Surg Oncol"},{"key":"1340_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/codi.14465","volume":"21","author":"B Pache","year":"2019","unstructured":"Pache B, H\u00fcbner M, Sol\u00e0 J, Hahnloser D, Demartines N, Grass F (2019) Receiver operating characteristic analysis to determine optimal fluid management during open colorectal surgery. Color Dis 21:234\u2013240. https:\/\/doi.org\/10.1111\/codi.14465","journal-title":"Color Dis"},{"key":"1340_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3109\/02656736.2015.1075606","volume":"31","author":"O Korakianitis","year":"2015","unstructured":"Korakianitis O, Daskalou T, Alevizos L, Stamou K, Mavroudis C, Iatrou C et al (2015) Lack of significant intraoperative coagulopathy in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) indicates that epidural anaesthesia is a safe option. Int J Hyperth 31:857\u2013862. https:\/\/doi.org\/10.3109\/02656736.2015.1075606","journal-title":"Int J Hyperth"},{"key":"1340_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijsu.2015.02.025","volume":"16","author":"F Piccioni","year":"2015","unstructured":"Piccioni F, Casiraghi C, Fumagalli L, Kusamura S, Baratti D, Deraco M et al (2015) Epidural analgesia for cytoreductive surgery with peritonectomy and heated intraperitoneal chemotherapy. Int J Surg 16:99\u2013106. https:\/\/doi.org\/10.1016\/j.ijsu.2015.02.025","journal-title":"Int J Surg"},{"key":"1340_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/02656736.2020.1742389","volume":"37","author":"M Tuovila","year":"2020","unstructured":"Tuovila M, Erkinaro T, Takala H, Savolainen ER, Laurila P, Ohtonen P et al (2020) Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study. Int J Hyperth 37:293\u2013300. https:\/\/doi.org\/10.1080\/02656736.2020.1742389","journal-title":"Int J Hyperth"},{"key":"1340_CR23","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","volume":"3","author":"DR Anderson","year":"2019","unstructured":"Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA et al (2019) American Society of Hematology 2019 guidelines for management of venous thromboembolism: Prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 3:3898\u20133944. https:\/\/doi.org\/10.1182\/bloodadvances.2019000975","journal-title":"Blood Adv"},{"key":"1340_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/01.anes.0000296719.73450.52","volume":"108","author":"S Rajagopalan","year":"2008","unstructured":"Rajagopalan S, Mascha E, Na J, Sessler DI (2008) The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 108:71\u201377. https:\/\/doi.org\/10.1097\/01.anes.0000296719.73450.52","journal-title":"Anesthesiology"},{"key":"1340_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/AOG.0b013e3182475f8a","volume":"119","author":"M Moslemi-Kebria","year":"2012","unstructured":"Moslemi-Kebria M, El-Nashar SA, Aletti GD, Cliby WA (2012) Intraoperative hypothermia during cytoreductive surgery for ovarian cancer and perioperative morbidity. Obstet Gynecol 119:590\u2013596. https:\/\/doi.org\/10.1097\/AOG.0b013e3182475f8a","journal-title":"Obstet Gynecol"},{"key":"1340_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/B978-0-444-64074-1.00041-0","volume":"157","author":"K Ruetzler","year":"2018","unstructured":"Ruetzler K, Kurz A (2018) Consequences of perioperative hypothermia. Handb Clin Neurol 157:687\u2013697. https:\/\/doi.org\/10.1016\/B978-0-444-64074-1.00041-0","journal-title":"Handb Clin Neurol"},{"key":"1340_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cursur.2004.02.002","volume":"61","author":"M Barak","year":"2004","unstructured":"Barak M, Rudin M, Vofsi O, Droyan A, Katz Y (2004) Fluid administration during abdominal surgery influences on coagulation in the postoperative period. Curr Surg 61:459\u2013462. https:\/\/doi.org\/10.1016\/j.cursur.2004.02.002","journal-title":"Curr Surg"},{"key":"1340_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1160\/TH09-06-0396","volume":"103","author":"SEM Schols","year":"2010","unstructured":"Schols SEM, Lanc\u00e9 MD, Feijge MAH, Damoiseaux J, Marcus MA, Hamuly\u00e1k K et al (2010) Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Thromb Haemost 103:318\u2013328. https:\/\/doi.org\/10.1160\/TH09-06-0396","journal-title":"Thromb Haemost"},{"key":"1340_CR29","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1213\/ANE.0000000000004479","volume":"130","author":"AY Mitrophanov","year":"2020","unstructured":"Mitrophanov AY, Szlam F, Sniecinski RM, Levy JH, Reifman J (2020) Controlled multifactorial coagulopathy: Effects of dilution, hypothermia, and acidosis on thrombin generation in vitro. Anesth Analg 130:1063\u20131076. https:\/\/doi.org\/10.1213\/ANE.0000000000004479","journal-title":"Anesth Analg"},{"key":"1340_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13304-020-00908-1","volume":"73","author":"M Tonello","year":"2021","unstructured":"Tonello M, Barina A, Turchet F, De Simoni O, Alfieri R, Franzato B et al (2021) Clinical and predictive value of blood lactate levels during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): a comparative analysis. Updates Surg 73:313\u2013319. https:\/\/doi.org\/10.1007\/s13304-020-00908-1","journal-title":"Updates Surg"},{"key":"1340_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193657","author":"S Van Poucke","year":"2018","unstructured":"Van Poucke S, Huskens D, Van der Speeten K, Roest M, Lauwereins B, Zheng MH et al (2018) Thrombin generation and platelet activation in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy\u2014a prospective cohort study. PLoS\u00a0One. https:\/\/doi.org\/10.1371\/journal.pone.0193657","journal-title":"PLoS\u00a0One"},{"key":"1340_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042741","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang Q, Chen L, Liu G, Liu PF (2020) Thromboelastography-guided blood transfusion during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Study protocol for a prospective randomised controlled trial. BMJ Open. https:\/\/doi.org\/10.1136\/bmjopen-2020-042741","journal-title":"BMJ Open"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-022-01340-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-022-01340-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:43:42Z","timestamp":1663328622000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-022-01340-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1340"],"URL":"https:\/\/doi.org\/10.1007\/s13304-022-01340-3","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"22 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by the Ethics Committee of the Veneto Institute of Oncology IOV-IRCCS (Qualy-HIPEC CE IOV 2018\/85).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study is a retrospective study, only involving case text and data analysis, not directly involving human and animal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants and\/or animals"}},{"value":"Consent to participate, Informed consent to participate was obtained from all the patients of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}